Genomatix know-how. Many facets. A clear picture.

Scientific Projects

Working with scientists and researchers outside the company has always been an important contribution to our aim to provide the best technologies for analyzing and interpreting biological data. Therefore we're always happy to collaborate in national and international scientific projects.


BLUEPRINT - A BLUEPRINT of Haematopoietic Epigenomes

The BLUEPRINT consortium has been formed with the aim of generating at least 100 reference epigenomes and studying them to advance and exploit knowledge of the underlying biological processes and mechanisms in health and disease. It is funded by the European Commission as a high impact project within its seventh framework program (FP7).

Genomatix' contributions will be next generation sequencing data analysis and the development of an intuitive GUI to make the project's results easily accessible to researchers within and outside the consortium.

Project web site:

European Commission project web site:


EURenOmics - European Consortium for High-Throughput Research in Rare Kidney Diseases

The EURenOmics consortium is devoted to improving the lives of patients affected by rare kidney diseases. In line with the objectives of the International Rare Disease Research Consortium (IRDiRC), it aims to develop novel tools that will allow to make more accurate diagnoses, predict the disease course and the efficacy of available treatments, and help developing new and better therapies for rare kidney diseases.This project is receiving funding as part of the European Community’s commitment to the IRDiRC initiative within its seventh framework programme (FP7).

Genomatix works on data integration and provides an analysis platform within the consortium.

Project web site:

European Commission project web site:


RADIANT - Rapid Development and Distribution of Statistical Tools for High-Throughput Sequencing Data

The aim of the RADIANT project is to develop new statistical analysis tools for solving open problems in high-throughput sequencing (HTS) data analysis. HTS is a rapidly evolving family of technologies with many applications, including genetics of both rare and common diseases, understanding disease mechanism progression. RADIANT aims to provide an integrated computational framework for HTS data analysis that is robust and user-friendly, and provide tools to benchmark experimental protocols and statistical methods. RADIANT is a research project funded by the 7th Framework Programme of the European Commission.

Among Genomatix' tasks within the project are development and improvement of algorithms as well as distribution of algorithms through commercial products.

Project web site:

European Commission project web site:


Prostate Cancer Prognostic Marker Discovery by Next Generation Sequencing -
Cooperation to further progress in prostate disease research.

Genomatix and the CPDR (the Center for Prostrate Disease Research of the Uniformed Services University of theHealth Sciences and the Henry M. Jackson Foundation) have entered into a Cooperative Research and Development Agreement (CRADA) to extend their collaborative endeavors in prostate disease research. The aim of the joint research will be to differentiate patients with favorable versus poor prognosis at the time of diagnosis and primary treatment using definitive genetic markers.

CPDR web site:

USUHS web site: